Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, ...

Novel antibodies have the potential to pave the way for the next generation of malaria interventions. Researchers at the ...

A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.

It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.

In a milestone for cellular research, eMBR Genomics and Axio BioPharma announce the first commercial availability of MKLP1 ...

NIH researchers discover novel class of antibodies that could lead to next generation of interventions against malaria.

Vir Biotechnology's recent share price rally is driven by their promising cancer program. Having shot to over a $1.5B market ...

The U.S. Centers for Disease Control and Prevention (CDC) currently recommends that everyone 75 and older receive a single ...

NIH researchers identified MAD21-101, a novel antibody targeting a previously unexplored epitope on the malaria parasite.